Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Clinical trial NCT03250117 · TERMINATED
Trial details
- NCT number
- NCT03250117
- Sponsor
- Titan Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2018-05-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.